Amiloidózis: vizsgálatok itt: Egyesült Államok
39 of 69 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of Ramantamig in Combination With Daratumumab With or Without Lenalidomide or of Single-agent JNJ-102299639 for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or Ramantamig in Combination With Pomalidomide for Multiple Myeloma
- Where
- Atlanta, Denver
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06768489 · EU 2024-515316-44-00 - 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Atlanta, Aurora, Austin, Baltimore, Boston, Brandon, Charleston, Charlotte, Charlottesville, Chicago, Cleveland, Columbus, Dallas, Detroit, Evanston, Falls Church, Gainesville, Houston, Indianapolis, Kansas City, Laguna Hills, La Jolla, Lancaster, Manhasset, Miami, New York, Norfolk, Norwich, Philadelphia, Plano, Portland, Richmond, Rochester, Salt Lake City, Seattle, Spokane, Stanford, St Louis, The Bronx, Tucker, Washington D.C.
- Életkor
- 18 év to 85 év
- People
- 2250 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - No phaseTaking peopleElevated Rate Pacing of Cardiac Amyloidosis
- Where
- Minneapolis
- Életkor
- 18 év and over
- People
- 10
- Run by
- University of Minnesota
See details and how to joinNCT07583823 - 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Ann Arbor, Atlanta, Baltimore, Boston, Charleston, Chicago, Cleveland, Columbus, Dallas, Denver, Detroit, Durham, Falls Church, Houston, Indianapolis, Jacksonville, Kansas City, Lexington, Los Angeles, Madison, New Haven, New York, Palo Alto, Philadelphia, Pittsburgh, Plano, Portland, Richmond, Rochester, San Diego, Tucson, Washington D.C., Weston
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 1. fázisTaking peopleA Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Where
- Charlotte, Denver, Duarte, Houston, Irvine, New York, Philadelphia, San Francisco
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05652335 · EU 2023-503679-12-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- Where
- Aurora, Boston, Hackensack, Los Angeles, Nashville, New Haven, Rochester, Salt Lake City
- Életkor
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07224672 · EU 2025-522803-60-00 - Korai 1. fázisNot yet taking people in Egyesült ÁllamokA Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
- Where
- Palo Alto
- Életkor
- 18 év and over
- People
- 5
- Run by
- Stanford University
See details and how to joinNCT07615270 - 3. fázisCsak meghívásosA Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Baltimore, Beverly Hills, Boston, Chicago, Cleveland, Columbus, Dallas, Durham, Glenview, Indianapolis, Kansas City, La Jolla, Nashville, New York, Omaha, Philadelphia, Phoenix, Rochester, Salt Lake City, Stanford, St Louis, Washington D.C.
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06679946 - 3. fázisTaking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Abington, Allentown, Ann Arbor, Austin, Baltimore, Boston, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Detroit, Durham, Falls Church, Farmington Hills, Gainesville, Glenview, Greenville, Hershey, Honolulu, Houston, Indianapolis, Kansas City, La Jolla, Lancaster, Los Angeles, Manhasset, Murray, Nashville, New Haven, New Orleans, New York, Norfolk, Omaha, Orange, Pasadena, Philadelphia, Phoenix, Plano, Portland, Richmond, Rochester, Rosedale, San Francisco, Santa Rosa, Spokane, Stanford, St Louis, The Bronx, Tupelo, Washington D.C.
- Életkor
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - 3. fázisTaking peopleTRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Aurora, Baltimore, Boston, Chapel Hill, Chicago, Dallas, Houston, Nashville, New York, Rochester
- Életkor
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00 - 2. fázisTaking peopleDaratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
- Where
- Rochester, Scottsdale
- Életkor
- 18 év and over
- People
- 96
- Run by
- Mayo Clinic
See details and how to joinNCT05898646 - 2. fázisTaking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Életkor
- 18 év and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - No phaseTaking peoplePrevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Where
- Boston
- Életkor
- 65 év and over
- People
- 515
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05577819 - 3. fázisNot yet taking people in Egyesült ÁllamokAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Atlanta, Aurora, Boston, Chapel Hill, Charleston, Cleveland, Columbus, Danville, Durham, Falls Church, Fort Worth, Greenville, Houston, Indianapolis, Irvine, Jacksonville, Kansas City, La Jolla, Madison, Memphis, New York, Palo Alto, Philadelphia, Portland, Richmond, Salt Lake City, San Francisco, Seattle, St Louis, Stony Brook, Washington D.C., Weston
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - 4. fázisTaking peopleUltrasound Therapy In Cardiac Amyloidosis
- Where
- Boston
- Életkor
- 18 év to 90 év
- People
- 70
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT04667494 - 1/2. fázisTaking peoplePhase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- Where
- Dallas, Nashville, Salt Lake City
- Életkor
- 18 év and over
- People
- 37
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT05145816 - 1/2. fázisTaking peopleElranatamab in Patients With Relapsed or Refractory AL Amyloidosis
- Where
- Boston, Cleveland, New Haven
- Életkor
- 18 év and over
- People
- 49
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06569147 - 1/2. fázisTaking peopleA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Where
- Boston, Buffalo, Columbus, Denver, Detroit, Duarte, Houston, Nashville
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00 - 1. fázisCsak meghívásosPET Imaging With [18F]Fluselenamyl in People With Cardiac Amyloidosis
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 50
- Run by
- Washington University School of Medicine
See details and how to joinNCT07771621 - 2. fázisNot yet taking people in Egyesült ÁllamokDose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis
- Where
- Cleveland, Rochester
- Életkor
- 18 év and over
- People
- 64
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07524634 - 3. fázisTaking peopleAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Where
- Atlanta, Aurora, Austin, Baltimore, Boston, Charleston, Chicago, Cleveland, Dallas, Detroit, Durham, Falls Church, Greenville, Jacksonville, Kansas City, La Jolla, Los Angeles, Miami, New Brunswick, New Haven, New York, Philadelphia, Pittsburgh, Portland, Richmond, Rochester, Rosedale, Salt Lake City, San Francisco, Seattle, Stanford, St Louis, Washington D.C., Weston
- Életkor
- 18 év to 75 év
- People
- 587 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00 - 4. fázisTaking peopleCardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Where
- St Louis
- Életkor
- 18 év to 80 év
- People
- 150 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07695701 · EU 2026-526068-19-00 - 1. fázisTaking peopleA Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
- Where
- Knoxville
- Életkor
- 18 év and over
- People
- 31
- Run by
- University of Tennessee Graduate School of Medicine
See details and how to joinNCT05951816 - No phaseCsak meghívásosAI Echocardiographic Screening of Cardiac Amyloidosis
- Where
- Chicago, Los Angeles, Palo Alto, Portland
- Életkor
- 22 év and over
- People
- 500
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT06664866 - No phaseTaking peopleCAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
- Where
- Charlotte
- Életkor
- 18 év and over
- People
- 50
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06096675